Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Qualcomm
QCOM
$155B
| $117M | 0.12% |
1,032,305
-63,472
| -6% | -$8.72M |
|
102
WillScot Mobile Mini Holdings
WSC
$4.39B
| $115M | 0.11% |
2,853,926
+610,003
| +27% | +$23.8M |
|
103
DTE Energy
DTE
$29.5B
| $113M | 0.11% |
985,181
+32,744
| +3% | +$4.23M |
|
104
Chord Energy
CHRD
$7.9B
| $113M | 0.11% |
828,020
+210,919
| +34% | +$27.1M |
|
|
HES
105
DELISTED
Hess
HES
| $110M | 0.11% |
1,009,526
-36,315
| -3% | -$4.02M |
|
106
Johnson Controls International
JCI
$88.8B
| $108M | 0.11% |
2,195,055
-15,982
| -0.7% | -$847K |
|
|
HZNP
107
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $108M | 0.11% |
1,741,110
+420,629
| +32% | +$29.4M |
|
108
Zoetis
ZTS
$32.4B
| $106M | 0.11% |
712,880
+28,218
| +4% | +$4.72M |
|
109
Deere & Co
DE
$160B
| $101M | 0.1% |
301,296
-15,898
| -5% | -$5.45M |
|
110
Xcel Energy
XEL
$48.8B
| $99.6M | 0.1% |
1,556,444
-209,101
| -12% | -$15.2M |
|
111
Molina Healthcare
MOH
$10.2B
| $95.9M | 0.1% |
290,684
+14,128
| +5% | +$4.55M |
|
|
MRSH
112
Marsh
MRSH
$90.5B
| $95.3M | 0.09% |
638,351
-52,268
| -8% | -$8.39M |
|
113
RenaissanceRe
RNR
$13.3B
| $95M | 0.09% |
676,472
+137,471
| +26% | +$19.1M |
|
114
Acadia Healthcare
ACHC
$2.76B
| $93.3M | 0.09% |
1,193,899
+137,428
| +13% | +$11M |
|
115
Trinity Industries
TRN
$2.49B
| $91.1M | 0.09% |
4,265,266
+815,420
| +24% | +$19.9M |
|
116
Shift4
FOUR
$4.2B
| $86.9M | 0.09% |
1,947,345
+331,352
| +21% | +$13.9M |
|
117
AXIS Capital
AXS
$7.68B
| $84.6M | 0.08% |
1,721,903
-96,556
| -5% | -$5.12M |
|
118
Tower Semiconductor
TSEM
$24.8B
| $83.7M | 0.08% |
1,905,744
+270,670
| +17% | +$12.5M |
|
|
CYBR
119
DELISTED
CyberArk
CYBR
| $83.1M | 0.08% |
+554,175
| New | +$79.1M |
|
120
Otis Worldwide
OTIS
$27.4B
| $83.1M | 0.08% |
1,301,994
+178,837
| +16% | +$13.1M |
|
|
121
TSMC
TSM
$2.1T
| $82.3M | 0.08% |
1,200,837
-5,233,177
| -81% | -$433M |
|
122
Envista
NVST
$4.44B
| $81M | 0.08% |
2,468,787
+139,657
| +6% | +$5.29M |
|
123
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $80.9M | 0.08% |
997,576
+213,504
| +27% | +$17.1M |
|
124
NXP Semiconductors
NXPI
$57.8B
| $80.5M | 0.08% |
545,965
-34,645
| -6% | -$5.8M |
|
125
Stryker
SYK
$125B
| $80.4M | 0.08% |
396,890
+60,357
| +18% | +$12.7M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.